January 31, 3013 — Analogic Corp. is acquiring Ultrasonix Medical Corp., a supplier of ultrasound systems for point-of-care and general imaging applications. Ultrasonix has more than 5,000 systems installed worldwide, and would bring key ultrasound products, technology and sales channels that are complementary to Analogic's ultrasound business.
"Once the acquisition is complete, Ultrasonix will be a significant contributor to Analogic's Ultrasound Group," said Farley Peechatka, senior vice president and general manager, global ultrasound business, Analogic. "With a solid installed base, superb portfolio of ultrasound products, unique GPS technology for needle guidance and intuitive graphical user interface, Ultrasonix will help accelerate our presence and growth in point-of-care applications in developed countries, and general imaging in emerging markets. We will continue to improve and advance both the Ultrasonix and BK Medical product lines to ensure that existing and new customers get the best products, support and service that we can offer."
Analogic and Ultrasonix are recognized as two of the world's leading producers of portable, procedure-driven, guided ultrasound technology. Founded in 2000, Ultrasonix has a broad portfolio of both portable and cart-based ultrasound systems with a recognized brand used primarily for point-of-care applications such as emergency medicine, anesthesia and reproductive medicine, as well as general imaging in emerging markets. Analogic's BK Medical ultrasound solutions are used to improve the practice of medicine in procedure-driven markets — urology, surgery and anesthesia. BK Medical's products, including its award-winning Flex Focus family of systems and unique transducer designs, offer advanced imaging capabilities that enable real-time image guidance in an easy-to-use, portable platform.
"We are eager to bring these comprehensive and complementary product portfolios together for an even stronger suite of advanced ultrasound systems for customers of both companies," said Lars Shaw, vice president of global marketing at Analogic. "In the point-of-care market, we believe our combined Anesthesia product portfolio will be much stronger. We anticipate that Ultrasonix will also complement our existing BK Medical urology and surgery product portfolio for both the hospital and office-based practice. We will continue to support Ultrasonix reproductive medicine customers with innovative technologies. Ultrasonix general imaging products are targeted for fast growing, emerging markets, which should allow us to better address emerging markets with a strong product portfolio."
The acquisition transaction is expected to close in late February 2013.
For more information, visit www.analogic.com, www.ultrasonix.com
April 24, 2024 
